| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | SOLUTION / OPHTHALMIC | 0.09 %w/v | | Exact identifier — unii candidate 61 equally ranked IID candidates |
| SUCROSE | SUCROSE | C151H8M554 | LIQUID / ORAL | | 37500 mg | Exact identifier — unii candidate 48 equally ranked IID candidates |
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | INJECTION, SOLUTION / SUBCUTANEOUS | | 25 mg | Exact identifier — unii candidate 61 equally ranked IID candidates |
| SUCROSE | SUCROSE | C151H8M554 | INJECTABLE, LIPOSOMAL / INTRAVENOUS | | 7560 mg | Exact identifier — unii candidate 48 equally ranked IID candidates |
| SUCROSE | SUCROSE | C151H8M554 | CAPSULE, DELAYED RELEASE / ORAL | | 955 mg | Exact identifier — unii candidate 48 equally ranked IID candidates |
| CALCIUM PHOSPHATE | CALCIUM PHOSPHATE | 97Z1WI3NDX | PASTE, DENTIFRICE / DENTAL | 45.93 %w/w | | Exact identifier — unii candidate 6 equally ranked IID candidates |
| SUCROSE | SUCROSE | C151H8M554 | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / SUBCUTANEOUS | | 308 mg | Exact identifier — unii candidate 48 equally ranked IID candidates |
| SUCROSE | SUCROSE | C151H8M554 | PASTILLE / ORAL | 426 mg | | Exact identifier — unii candidate 48 equally ranked IID candidates |
| ACESULFAME POTASSIUM | ACESULFAME POTASSIUM | 23OV73Q5G9 | TABLET, ORALLY DISINTEGRATING / ORAL | | 24 mg | Exact identifier — unii candidate 17 equally ranked IID candidates |
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | CREAM / VAGINAL | | 51 mg | Exact identifier — unii candidate 49 equally ranked IID candidates |
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE / ORAL | | 300 mg | Exact identifier — unii candidate 49 equally ranked IID candidates |
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | PELLET / ORAL | | 34 mg | Exact identifier — unii candidate 49 equally ranked IID candidates |
| SUCROSE | SUCROSE | C151H8M554 | WAFER / ORAL | 155.2 mg | | Exact identifier — unii candidate 48 equally ranked IID candidates |
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | FILM / BUCCAL | | 9 mg | Exact identifier — unii candidate 61 equally ranked IID candidates |
| SUCROSE | SUCROSE | C151H8M554 | INJECTION, POWDER, FOR SUSPENSION / INTRAVENOUS | 900 mg | | Exact identifier — unii candidate 48 equally ranked IID candidates |
| ASPARTAME | ASPARTAME | Z0H242BBR1 | POWDER, FOR SOLUTION / ORAL | 233 mg | | Exact identifier — unii candidate 19 equally ranked IID candidates |
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | TABLET, ORALLY DISINTEGRATING / SUBLINGUAL | ADJ PH | | Exact identifier — unii candidate 61 equally ranked IID candidates |
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, EXTENDED RELEASE / ORAL | | 450 mg | Exact identifier — unii candidate 49 equally ranked IID candidates |
| MALTODEXTRIN | MALTODEXTRIN | 7CVR7L4A2D | FILM, SOLUBLE / ORAL | | 19 mg | Exact identifier — unii candidate 15 equally ranked IID candidates |
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | LOTION / TOPICAL | | 211 mg | Exact identifier — unii candidate 61 equally ranked IID candidates |
| ASPARTAME | ASPARTAME | Z0H242BBR1 | POWDER / ORAL | | 63 mg | Exact identifier — unii candidate 19 equally ranked IID candidates |
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | | 48 mg | Exact identifier — unii candidate 61 equally ranked IID candidates |
| ACESULFAME POTASSIUM | ACESULFAME POTASSIUM | 23OV73Q5G9 | FILM, SOLUBLE / ORAL | | 10 mg | Exact identifier — unii candidate 17 equally ranked IID candidates |
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET / ORAL | | 750 mg | Exact identifier — unii candidate 49 equally ranked IID candidates |
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE, EXTENDED RELEASE / ORAL | | 168 mg | Exact identifier — unii candidate 49 equally ranked IID candidates |
| SUCROSE | SUCROSE | C151H8M554 | LOZENGE / BUCCAL | NA | | Exact identifier — unii candidate 48 equally ranked IID candidates |
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | | 69 mg | Exact identifier — unii candidate 49 equally ranked IID candidates |
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | POWDER / RESPIRATORY (INHALATION) | NA | | Exact identifier — unii candidate 49 equally ranked IID candidates |
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | SPRAY, METERED / NASAL | 1.2 mg/1ml | | Exact identifier — unii candidate 61 equally ranked IID candidates |
| CALCIUM PHOSPHATE | CALCIUM PHOSPHATE | 97Z1WI3NDX | POWDER, DENTIFRICE / DENTAL | 0.11 mg/mg | | Exact identifier — unii candidate 6 equally ranked IID candidates |
| MALTODEXTRIN | MALTODEXTRIN | 7CVR7L4A2D | TABLET, ORALLY DISINTEGRATING / ORAL | | 12 mg | Exact identifier — unii candidate 15 equally ranked IID candidates |
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | TABLET, CHEWABLE / ORAL | | 4 mg | Exact identifier — unii candidate 61 equally ranked IID candidates |
| ASPARTAME | ASPARTAME | Z0H242BBR1 | GRANULE, EFFERVESCENT / ORAL | 30 mg | | Exact identifier — unii candidate 19 equally ranked IID candidates |
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | INJECTION / INTRAMUSCULAR | | 101 mg | Exact identifier — unii candidate 61 equally ranked IID candidates |
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE, DELAYED RELEASE / ORAL | | 40 mg | Exact identifier — unii candidate 49 equally ranked IID candidates |
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | TAMPON / VAGINAL | NA | | Exact identifier — unii candidate 49 equally ranked IID candidates |
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE, COATED, EXTENDED RELEASE / ORAL | NA | | Exact identifier — unii candidate 49 equally ranked IID candidates |
| SUCROSE | SUCROSE | C151H8M554 | CAPSULE, COATED PELLETS / ORAL | 59.8 mg | | Exact identifier — unii candidate 48 equally ranked IID candidates |
| ACESULFAME POTASSIUM | ACESULFAME POTASSIUM | 23OV73Q5G9 | TABLET / SUBLINGUAL | | 13 mg | Exact identifier — unii candidate 17 equally ranked IID candidates |
| ASPARTAME | ASPARTAME | Z0H242BBR1 | SYRUP / ORAL | 0.63 mg/5ml | | Exact identifier — unii candidate 19 equally ranked IID candidates |
| MALTODEXTRIN | MALTODEXTRIN | 7CVR7L4A2D | LOZENGE / ORAL | | 175 mg | Exact identifier — unii candidate 15 equally ranked IID candidates |
| SUCROSE | SUCROSE | C151H8M554 | GRANULE, FOR SUSPENSION / ORAL | | 31885 mg | Exact identifier — unii candidate 48 equally ranked IID candidates |
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, COATED / ORAL | | 176 mg | Exact identifier — unii candidate 49 equally ranked IID candidates |
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | SYRUP / ORAL | | 268 mg | Exact identifier — unii candidate 61 equally ranked IID candidates |
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | SUSPENSION / ORAL | | 400 mg | Exact identifier — unii candidate 49 equally ranked IID candidates |
| SUCROSE | SUCROSE | C151H8M554 | POWDER, FOR SUSPENSION / ORAL | | 40017 mg | Exact identifier — unii candidate 48 equally ranked IID candidates |
| SUCROSE | SUCROSE | C151H8M554 | SUSPENSION / ORAL | | 48209 mg | Exact identifier — unii candidate 48 equally ranked IID candidates |
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | TABLET / BUCCAL | | 30 mg | Exact identifier — unii candidate 61 equally ranked IID candidates |
| ACESULFAME POTASSIUM | ACESULFAME POTASSIUM | 23OV73Q5G9 | POWDER, FOR SUSPENSION / ORAL | 45 mg/5ml | | Exact identifier — unii candidate 17 equally ranked IID candidates |
| SUCROSE | SUCROSE | C151H8M554 | CONCENTRATE / ORAL | | 4800 mg | Exact identifier — unii candidate 48 equally ranked IID candidates |
| MALTODEXTRIN | MALTODEXTRIN | 7CVR7L4A2D | TABLET / ORAL | | 320 mg | Exact identifier — unii candidate 15 equally ranked IID candidates |
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | INJECTION / INTRAVENOUS | | 1152 mg | Exact identifier — unii candidate 61 equally ranked IID candidates |
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | INJECTION / INFILTRATION | 0.02 %w/v | | Exact identifier — unii candidate 61 equally ranked IID candidates |
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, ORALLY DISINTEGRATING / ORAL | | 68 mg | Exact identifier — unii candidate 49 equally ranked IID candidates |
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | GRANULE, FOR SUSPENSION / ORAL | | 30 mg | Exact identifier — unii candidate 61 equally ranked IID candidates |
| SUCROSE | SUCROSE | C151H8M554 | CAPSULE / ORAL | | 3568 mg | Exact identifier — unii candidate 48 equally ranked IID candidates |
| SUCROSE | SUCROSE | C151H8M554 | TABLET / SUBLINGUAL | 109 mg | | Exact identifier — unii candidate 48 equally ranked IID candidates |
| SUCROSE | SUCROSE | C151H8M554 | INJECTION, SOLUTION / INTRAVENOUS | NA | | Exact identifier — unii candidate 48 equally ranked IID candidates |
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE, LIQUID FILLED / ORAL | | 106 mg | Exact identifier — unii candidate 49 equally ranked IID candidates |
| ASPARTAME | ASPARTAME | Z0H242BBR1 | TABLET, CHEWABLE, EXTENDED RELEASE / ORAL | | 18 mg | Exact identifier — unii candidate 19 equally ranked IID candidates |